CARBIDOPA AND LEVODOPA
RUBICON RESEARCH · CARBIDOPA, LEVODOPA
Open FDA's page for this record- Application number
- ANDA217482
- Sponsor name
- RUBICON RESEARCH
- Submissions
- Submission type
- SUPPL
- Submission number
- 3
- Submission status
- AP
- Submission status date
- 20260528
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20240604
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Products
- Product number
- 002
- Reference drug
- No
- Brand name
- CARBIDOPA AND LEVODOPA
- Reference standard
- No
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- CARBIDOPA
- Strength
- 50MG
- Name
- LEVODOPA
- Strength
- 200MG
- Product number
- 001
- Reference drug
- No
- Brand name
- CARBIDOPA AND LEVODOPA
- Reference standard
- No
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- CARBIDOPA
- Strength
- 25MG
- Name
- LEVODOPA
- Strength
- 100MG
- Harmonized identifiers (openFDA)
- Application number
- ANDA217482
- Brand name
- CARBIDOPA AND LEVODOPA
- Generic name
- CARBIDOPA AND LEVODOPA
- Manufacturer name
- Advagen Pharma Ltd
- Product NDC
- 72888-155, 72888-156
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- CARBIDOPA, LEVODOPA
- RxCUI
- 308988, 308989
- SPL ID
- 519a4143-7efb-81ab-e063-6394a90a219b
- SPL set ID
- 5b6519ff-d1af-402b-83eb-b4fce6743a18
- Package NDC
- 72888-155-30, 72888-155-01, 72888-155-05, 72888-155-00, 72888-156-30, 72888-156-01, 72888-156-05, 72888-156-00
- Nui
- N0000193220, M0370111, N0000175754, N0000175755
- Pharm class epc
- Aromatic Amino Acid [EPC], Aromatic Amino Acid Decarboxylation Inhibitor [EPC]
- Pharm class cs
- Amino Acids, Aromatic [CS]
- Pharm class moa
- DOPA Decarboxylase Inhibitors [MoA]
- UNII
- 46627O600J, MNX7R8C5VO
